Helsinn is a privately owned pharmaceutical group headquartered in Lugano, Switzerland, with operating subsidiaries in Ireland, the U.S. and a representative office in China. Helsinn is one of the world’s leading supportive cancer care companies. Our portfolio of products combines therapies we license and therapies developed at Helsinn. www.helsinn.com